Literature DB >> 29677548

Combination of curcumin and vagus nerve stimulation attenuates cerebral ischemia/reperfusion injury-induced behavioral deficits.

Jian Xu1, Xinjuan Kong2, Hong Xiu3, Yihe Dou1, Zeyu Wu1, Peng Sun4.   

Abstract

AIM: Previous studies indicated that cerebral ischemia/reperfusion injury (CI/RI) could induce behavioral deficits. Single treatment of vagus nerve stimulation (VNS) or curcumin is reported to restore CI/RI-induced behavioral deficits. However, the synergic effect remains unclear.
MATERIALS AND METHODS: Rats were divided into 6 groups: sham, CI/RI, VNS, CI/RI + VNS, VNS + curcumin and CI/RI + VNS + curcumin groups. Each group was further divided into three or four subgroups for further assessments. In specific, Morris water maze task and shuttle box test were used to evaluate cognitive capacity. Rota-rod test, neurological deficits scores, 2,3,5-triphenyltetrazolium chloride staining, TUNEL staining were performed to estimate motor capacity, neurological deficits, the size of infarct volume and neural apoptosis, respectively. Finally, the expressions of apoptosis-associated proteins and key kinases in the AKT/extracellular signal-regulated kinase-2 (ERK2) pathway were measured by Western blot analysis.
RESULTS: Combination of curcumin and VNS significantly restored the CI/RI-induced cognitive and motor impairments compared with the CI/RI + VNS group (P < 0.05 and P < 0.01). Moreover, combination of curcumin and VNS significantly lowered CI/RI-induced neurological deficits, infract volume, neural apoptosis (all P < 0.05) and inflammatory cytokines release (P < 0.05 and P < 0.01) when compared to the CI/RI + VNS group. Additionally, the phosphorylation levels of AKT and ERK2 were both increased by combination of curcumin and VNS compared with the CI/RI + VNS group.
CONCLUSION: Combination of curcumin and VNS restored CI/RI-induced behavioral deficits by inhibiting apoptosis and inflammatory response. Besides, the AKT/ERK2 pathway might be implicated.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  AKT/ERK2; Behavioral deficits; Cerebral ischemia/reperfusion injury; Curcumin; Inflammatory cytokines; Vagus nerve stimulation

Mesh:

Substances:

Year:  2018        PMID: 29677548     DOI: 10.1016/j.biopha.2018.04.069

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  5 in total

1.  Theaflavin attenuates cerebral ischemia/reperfusion injury by abolishing miRNA‑128‑3p‑mediated Nrf2 inhibition and reducing oxidative stress.

Authors:  Ronggang Li; Xin Li; Haibing Wu; Zhikun Yang; Li Fei; Jianhong Zhu
Journal:  Mol Med Rep       Date:  2019-10-17       Impact factor: 2.952

2.  Alteration of N 6 -Methyladenosine mRNA Methylation in a Rat Model of Cerebral Ischemia-Reperfusion Injury.

Authors:  Dazhuang Yi; Qunhui Wang; Yuhao Zhao; Yu Song; Hong You; Jian Wang; Renjie Liu; Zhongqiang Shi; Xuan Chen; Qi Luo
Journal:  Front Neurosci       Date:  2021-03-16       Impact factor: 4.677

Review 3.  Neuroprotective Effect for Cerebral Ischemia by Natural Products: A Review.

Authors:  Qian Xie; Hongyan Li; Danni Lu; Jianmei Yuan; Rong Ma; Jinxiu Li; Mihong Ren; Yong Li; Hai Chen; Jian Wang; Daoyin Gong
Journal:  Front Pharmacol       Date:  2021-04-22       Impact factor: 5.810

Review 4.  Mechanisms Underlying Curcumin-Induced Neuroprotection in Cerebral Ischemia.

Authors:  Feng Fan; Meng Lei
Journal:  Front Pharmacol       Date:  2022-04-26       Impact factor: 5.988

5.  Pinoresinol diglucoside alleviates ischemia/reperfusion-induced brain injury by modulating neuroinflammation and oxidative stress.

Authors:  Yi Zhang; Yuanbiao Lei; Xiaoxi Yao; Jiping Yi; Ganghua Feng
Journal:  Chem Biol Drug Des       Date:  2021-10-03       Impact factor: 2.873

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.